Morphological properties of articular chondrocytes in various experimental and clinical conditions
Item Status
Embargo End Date
Date
Authors
Abstract
Previous work has suggested that there exists a relationship between chondrocyte
morphology and matrix metabolism. Changes to chondrocyte morphology have been
reported in human cartilage however it is unclear if these are involved in the
degenerative process associated with osteoarthritis (OA). In this work, the
morphology of human and bovine chondrocytes has been characterised under a range
of conditions. Bovine chondrocytes have been utilised in these experiments as bovine
cartilage is non-degenerate and the chondrocytes have ‘normal’ morphology.
However, if human cartilage have been used instead then there is possibility of
having chondrocytes of mixed shapes i.e. both ‘normal’ and ‘abnormal’ cells. The
thesis aimed at experimentally inducing morphological changes to chondrocytes to
determine whether these changes resemble those observed in human cartilage. The
ultimate aim is to model these changes to clarify the link between morphology and
matrix metabolism by determining how morphological changes influence matrix
metabolism.
A classification system was developed for chondrocyte morphology allowing the
quantification of chondrocyte shapes under different conditions permitting statistical
comparisons. The different conditions utilised were (1) non-degenerate and mildly-degenerate
human articular cartilage and (2) two in vitro models (a) weak 3D agarose
gels to study the effect of gel strength and increasing concentrations of foetal calf
serum (FCS) on morphology of bovine chondrocytes and (b) scalpel induced
mechanically-injured bovine cartilage model to study in situ chondrocyte viability
and morphology at the injured site in various culture conditions. Additionally, the
effect of raised medium osmolarity on the response of chondrocytes to injury was
studied to determine if the abnormal morphology could be reversed.
Using fluorescence-mode confocal laser scanning microscopy (CLSM), chondrocyte
viability, volume and morphology were determined and quantified by using
VolocityTM 3D image analysis software. Histological evaluation of matrix by using
Haematoxylin and eosin, Alcian blue and Masson’s trichrome staining of matrix
produced by chondrocytes cultured in strong or weak agarose gels and in injured
cartilage was determined. Additionally, immunohistochemical evaluation of matrix
(collagen Types I & II) produced by chondrocytes was also performed.
Results demonstrated that in non-degenerate human femoral head cartilage, ~83%
chondrocytes were normal in morphology and 17±2% chondrocytes had cytoplasmic
processes as compared to mildly-degenerate cartilage where 35±5% abnormal
chondrocytes with cytoplasmic processes were present. In non-degenerate cartilage,
11±3% chondrocytes formed small sized clusters however clustering was quite
evident in the superficial zone of mildly-degenerate human femoral head cartilage
where 43±16% chondrocytes had formed large clusters. In mildly-degenerate
cartilage the number of abnormal chondrocytes with processes, length of processes
and number of processes per cell were greater in the superficial as compared to mid
and deep zones.
A model was developed to study the effect of external supporting agarose gel on
chondrocyte morphology and also to determine the influence of FCS. Bovine
chondrocytes cultured in weak gels after 7 days developed similar morphological
changes as those observed in degenerate human cartilage. However, in the strong
gels only few chondrocytes with morphological changes were present i.e. similar to
non-degenerate cartilage. These morphological changes (development of clusters and
processes) occurred more rapidly with increasing concentrations of FCS. Histology
revealed less Alcian blue staining intensity around chondrocytes cultured in weak
gels as compared to strong gels suggesting altered matrix produced by abnormal
chondrocytes. FCS and gel strength were therefore proposed as related factors in
regulating chondrocyte morphology.
In the bovine injured cartilage explant model, after 14 days chondrocytes at the
injury in the presence of FCS or synovial fluid (SF) produced morphological
changes. These changes comprised cell enlargement, flattening, elongation and
production of cytoplasmic processes. In the absence of FCS or SF, chondrocytes at
the injury remained unaffected and were morphologically ‘normal’. Throughout the
cartilage and even in the absence of subchondral bone, chondrocytes displayed
morphological abnormalities in the presence of FCS or SF. These findings suggested
that this is not the property of chondrocytes in the superficial layers alone rather it is
due to the extent of penetration of the ‘factors’ into the matrix and there is no
possibility of interference of injured site with osteocytes or bone factors. Histology
revealed that these abnormal chondrocytes showed less staining with Alcian blue at
the injury suggesting that these morphological changes might play a role in the
changes to matrix metabolism. By raising the osmolarity of the culture medium these
changes were inhibited and chondrocytes maintained their normal morphology.
The results suggest that morphogenic/proliferative factors in FCS or SF and
strength/damage to the matrix may be inter-related and act as potent controllers of
chondrocyte morphology. Raised osmolarity was found to inhibit the morphological
changes suggesting the possibly that hyperosmolarity can antagonise the effects of
these factors. The key conclusions from the thesis were (a) in non-degenerate human
femoral cartilage a large percentage of chondrocytes ~83% were normal in
morphology and the rest were abnormal however in mildly-degenerate cartilage
35±5% abnormal chondrocytes with processes were present (b) the changes to
chondrocyte morphology (development of clusters and processes) were exacerbated
with cartilage degeneration (c) chondrocytes cultured in the weak gels produced
morphological changes as compared to strong gels (d) chondrocytes at the injury
displayed marked morphological changes in the presence of FCS or SF (e) by raising
the medium osmolarity these morphological changes to chondrocytes at the injury
were inhibited. These results show that chondrocyte morphology is complex and
strongly dependent on the environmental settings. Experimental conditions were
therefore identified which showed increased chondrocyte volume, abnormal
morphology with cytoplasmic processes, enhanced proliferation/cluster formation
and matrix changes. These changes to volume and morphology of chondrocytes in
the models studied in this work had certain similarities to the changes observed in
human cartilage suggesting that these shape changes may play a role in the changes
to matrix metabolism occurring in OA.
These findings may be of translational relevance in clinical and experimental
research into cartilage injury and degeneration by providing new insights in
understanding the role played by chondrocyte morphology in cartilage degeneration
and injury.
This item appears in the following Collection(s)

